GE HealthCare announces FDA clearance for Aurora, dual-head SPECT/CT, and Clarify DL, AI-powered image reconstruction ...
CHICAGO — May 5, 2025 — GE HealthCare (Nasdaq: GEHC) today is proud to announce that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance of its impressive Aurora nuclear medicine system and Clarify DL.ii This advanced dual-head SPECT/ …